Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Classification of prostanoid receptors.

P J Gardiner1

  • 1Bayer U.K. Research Dept. Pharmaceutical Business Group, Stoke Poges, England.

Advances in Prostaglandin, Thromboxane, and Leukotriene Research
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the ORSIM® simulator for assessment of anaesthetists' skills in flexible bronchoscopy: aspects of validity and reliability.

British journal of anaesthesia·2016
Same author

The effects of a novel sulphidopeptide leukotriene antagonist, BAY x7195, against elicited bronchoconstriction in the anaesthetized guinea-pig.

British journal of pharmacology·1998
Same author

Leukotriene receptors on human pulmonary vascular endothelium.

British journal of pharmacology·1995
Same author

Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature.

Advances in prostaglandin, thromboxane, and leukotriene research·1995
Same author

Characterisation of leukotriene receptors on rat lung strip.

European journal of pharmacology·1994
Same author

BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes.

European journal of pharmacology·1994

The existence of five prostanoid receptor types is supported by new drug studies. Selective agonists and antagonists help identify therapeutic targets for future prostanoid drugs.

Area of Science:

  • Pharmacology
  • Drug Discovery

Background:

  • The classification of prostanoid receptor types is evolving.
  • Selective agonists and antagonists are crucial pharmacological tools.

Purpose of the Study:

  • To strengthen the hypothesis of five distinct prostanoid receptor types.
  • To explore the use of selective compounds in drug development.

Main Methods:

  • Testing selective agonists and antagonists.
  • Probing prostanoid receptor involvement in tissues and diseases.

Main Results:

  • Studies testing selective compounds have strengthened the initial hypothesis.
  • Pharmacological tools are effective in identifying receptor involvement.

Related Experiment Videos

Conclusions:

  • The approach using selective compounds is likely to yield new therapeutic products in the prostanoid field.
  • Further refinement of prostanoid receptor classification is expected with new tools.